Cargando…

Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report

Oxaliplatin is a third-generation platinum derivative used for metastatic or advanced colorectal cancer treatment. Although myelosuppression is the most common cause of oxaliplatin-induced thrombocytopenia, rare cases of oxaliplatin-induced immune-mediated thrombocytopenia are reported. We report a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woo, Hyun Sun, Lee, Kyoung Hwa, Yoon, Phill Hoon, Kim, Su Ji, Park, Inkeun, Kim, Young Saing, Ahn, Hee Kyung, Hong, Junshik, Shin, Dong Bok, Sym, Sun Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614196/ https://www.ncbi.nlm.nih.gov/pubmed/25544580 http://dx.doi.org/10.4143/crt.2014.052

Ejemplares similares

Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy
por: Park, Inkeun, et al.
Publicado: (2016)

Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer
por: Baek, Min Young, et al.
Publicado: (2018)

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
por: Kim, Young Saing, et al.
Publicado: (2016)

Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer: A Retrospective Analysis
por: Park, Joo-Hwan, et al.
Publicado: (2022)

Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy
por: Hong, Junshik, et al.
Publicado: (2014)

Unusual radiologic manifestation of pseudoprogression in pulmonary metastases after durvalumab treatment in metastatic bladder urothelial cancer
por: Kim, Eun Young, et al.
Publicado: (2019)

Antiplatelet antibodies in oxaliplatin-induced immune thrombocytopenia
por: Mittal, Kriti, et al.
Publicado: (2014)

A Prospective Study of Chronic Oxaliplatin-Induced Neuropathy in Patients with Colon Cancer: Long-Term Outcomes and Predictors of Severe Oxaliplatin-Induced Neuropathy
por: Kim, Su-Hyun, et al.
Publicado: (2018)

A Phase II Study of Cetuximab (Erbitux®) plus FOLFIRI for Irinotecan and Oxaliplatin-refractory Metastatic Colorectal Cancer
por: Koo, Dong Hoe, et al.
Publicado: (2007)

Concordance Rate between Clinicians and Watson for Oncology among Patients with Advanced Gastric Cancer: Early, Real-World Experience in Korea
por: Choi, Youn I, et al.
Publicado: (2019)

A case of oxaliplatin-induced immune-mediated thrombocytopenia
por: Suh, Seong Eun, et al.
Publicado: (2014)

Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
por: Pan, Elizabeth, et al.
Publicado: (2018)

Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study
por: Nam, Chang Hyun, et al.
Publicado: (2021)

Additional rituximab-CHOP (R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysis
por: Hong, Junshik, et al.
Publicado: (2010)

The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer
por: Kim, Eun Young, et al.
Publicado: (2016)

Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI
por: Kim, Eun Young, et al.
Publicado: (2016)

Acute Immune-Mediated Thrombocytopenia due to Oxaliplatin and Irinotecan Therapy
por: Tam, Eric L., et al.
Publicado: (2019)

Sarcoidosis Associated with Oxaliplatin-Based Chemotherapy for Colorectal Cancer
por: Choi, Ji Hoon, et al.
Publicado: (2014)

Epidermal Growth Factor Receptor Mutations and the Clinical Outcome in Male Smokers with Squamous Cell Carcinoma of Lung
por: Park, Se Hoon, et al.
Publicado: (2009)

Postsplenectomy Recurrence of Thrombocytopenia with an Accessory Spleen
por: Woo, Jin Hyun, et al.
Publicado: (2004)

S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial
por: Kim, Seung Tae, et al.
Publicado: (2014)

Pemetrexed versus Gefitinib versus Erlotinib in Previously Treated Patients with Non-Small Cell Lung Cancer
por: Hong, Junshik, et al.
Publicado: (2010)

Hyperferritinemia as a Diagnostic Marker for Severe Fever with Thrombocytopenia Syndrome
por: Kim, Uh Jin, et al.
Publicado: (2017)

Helicobacter pylori eradication affects platelet count recovery in immune thrombocytopenia
por: Lee, Ayoung, et al.
Publicado: (2020)

Vaccine-Induced Immune Thrombotic Thrombocytopenia: First Case Report in South Korea
por: Kim, Min Kyung, et al.
Publicado: (2021)

A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
por: Ahn, Hee Kyung, et al.
Publicado: (2014)

Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy
por: Lee, Dae-Won, et al.
Publicado: (2019)

Author Correction: Helicobacter pylori eradication affects platelet count recovery in immune thrombocytopenia
por: Lee, Ayoung, et al.
Publicado: (2020)

Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07
por: Kim, Seung Tae, et al.
Publicado: (2022)

A Muti-center, Randomized Phase II Study of Oxaliplatin and S-1 versus Capecitabine and Oxaliplatin in Patients with Metastatic Colorectal Cancer
por: Kim, Jung Han, et al.
Publicado: (2015)

Severe Fever with Thrombocytopenia Syndrome Virus in Ticks in the Republic of Korea
por: Kang, Jun-Gu, et al.
Publicado: (2022)

Transient thrombocytopenia in a cat following G‐CSF treatment
por: Kim, Kyeong‐Bo, et al.
Publicado: (2021)

Tumor Lysis Syndrome in a Patient with Metastatic Colon Cancer after Treatment with 5-Fluorouracil/Leucovorin and Oxaliplatin: Case Report and Literature Review
por: Kim, Hyung Duk, et al.
Publicado: (2014)

Management of immune thrombocytopenia: Korean experts recommendation in 2017
por: Jang, Jun Ho, et al.
Publicado: (2017)

Syringaresinol Alleviates Oxaliplatin-Induced Neuropathic Pain Symptoms by Inhibiting the Inflammatory Responses of Spinal Microglia
por: Lee, Ji Hwan, et al.
Publicado: (2022)

Clinical features and epidemiology of severe fever with thrombocytopenia syndrome in dogs in the Republic of Korea: an observational study (2019–2020)
por: Han, Sun-Woo, et al.
Publicado: (2022)

Factors Influencing Clinicians' Choice of Adjuvant S-1 versus Capecitabine plus Oxaliplatin after Curative Gastrectomy in Patients with Gastric Cancer
por: Lee, Ha Yeon, et al.
Publicado: (2016)

Oxaliplatin-Induced Thrombocytopenia: A Case Report and Review of Pathophysiology of Various Speculative Mechanisms
por: Ghazanfar, Haider, et al.
Publicado: (2020)

Baseline renal function as a prognostic indicator in patients with newly diagnosed diffuse large B-cell lymphoma
por: Hong, Junshik, et al.
Publicado: (2016)

Romiplostim-related myelofibrosis in refractory primary immune thrombocytopenia: A Case report
por: Kim, Hyun-Young, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_045korrsl8t13u6i57gbq5g7vg